Relationship between megakaryocyte mass and serum thrombopoietin levels as revealed by a case of cyclic amegakaryocytic thrombocytopenic purpura

British Journal of Haematology - Tập 105 Số 2 - Trang 452-458 - 1999
Claire Francastel1, Janina Ratajczak, Mariusz Z. Ratajczak, John Anastasi, Philip C. Hoffman, Alan M. Gewirtz
1Section of Hematology/Oncology, Department of Internal Medicine, University of Chicago, Illinois, USA.

Tóm tắt

Cyclic amegakaryocytic thrombocytopenic purpura is a rare syndrome characterized by periodic failure of megakaryocytopoiesis. In this report we describe a patient with cyclic amegakaryocytic thrombocytopenic purpura associated with a megakaryocyte specific serum IgG antibody, who responded to cyclosporin A therapy. Serial serum thrombopoietin assays during an episode of platelet cycling demonstrated a reciprocal relationship between serum thrombopoietin level and megakaryocyte mass, suggesting that megakaryocytes have an important role in the regulation of thrombopoietin metabolism.

Từ khóa


Tài liệu tham khảo

10.1056/NEJM199406023302203

Andrew S.&Titus J.(1997) Antibody detection and preparation. InCurrent Protocols in Immunology(ed. by J. Coligan A. Kruisbeek D. Margulies E. Shevach and W. Strober) pp.2.7.4–2.7.6and2.8.3–2.8.4.

10.1111/j.1600-0609.1977.tb01475.x

10.1111/j.1365-2141.1993.tb03214.x

10.1016/0092-8674(94)90450-2

Cohen‐Solal K., 1996, Constitutive expression of Mpl ligand transcripts during thrombocytopenia or thrombocytosis, Blood, 88, 2578, 10.1182/blood.V88.7.2578.bloodjournal8872578

10.1111/j.1365-2141.1991.tb08585.x

Debili N., 1995, The Mpl receptor is expressed in the megakaryocyte lineage from late progenitors to platelets, Blood, 85, 391, 10.1182/blood.V85.2.391.391

10.1084/jem.183.2.651

10.1038/369533a0

10.1046/j.1365-2141.1996.4871026.x

10.1182/blood.V87.10.4068.bloodjournal87104068

10.1111/j.1600-0609.1966.tb02373.x

10.1182/blood.V87.6.2154.bloodjournal8762154

10.1111/j.1365-2141.1986.tb02937.x

10.1182/blood.V67.6.1639.1639

Gewirtz A., 1986, Cell‐mediated suppression of megakaryocytopoiesis in acquired amegakaryocytic thrombocytopenic purpura, Blood, 68, 619, 10.1182/blood.V68.3.619.619

10.1126/science.8073287

10.1056/NEJM198504183121614

10.1056/NEJM198907133210207

10.1182/blood.V60.5.1173.1173

10.1056/NEJM198505023121807

10.2169/internalmedicine.33.147

10.1046/j.1365-2141.1996.d01-1702.x

Kosugi S., 1994, Cyclic thrombocytopenia associated with IgM anti‐GPIIb–IIIa autoantibodies, British Journal of Haematology, 3, 290

10.1073/pnas.91.23.11104

10.1182/blood.V84.5.1464.1464

Kuter D., 1995, The reciprocal relationship of thrombopoietin (c‐Mpl ligand) to changes in platelet mass during busulfan‐induced thrombocytopenia in the rabbit, Blood, 85, 2720, 10.1182/blood.V85.10.2720.bloodjournal85102720

10.1038/369568a0

10.1046/j.1365-2141.1996.d01-1966.x

Mazur E., 1984, Human serum megakaryocyte colony‐stimulating activity increases in response to intensive cytotoxic chemotherapy, Experimental Hematology, 12, 624

10.1182/blood.V73.6.1561.1561

10.1172/JCI118005

Ratajczak M., 1998, In vitro and in vivo evidence that ex vivo cytokine priming of donor marrow cells may ameliorate post transplant thrombocytopenia, Blood, 91, 353, 10.1182/blood.V91.1.353

10.1046/j.1365-2141.1996.d01-1736.x

10.1016/0092-8674(95)90531-6

10.1016/0092-8674(90)90410-G

10.1182/blood.V87.2.567.bloodjournal872567

10.1046/j.1365-2141.1996.d01-1741.x

10.1111/j.1365-2141.1989.tb00232.x

10.1038/369571a0

10.1159/000204510